(Q54348663)

28 May 2018

title

Promoter methylation status and expression of estrogen receptor alpha in familial breast cancer patients. (English)

1 reference

28 May 2018

author name string

Jing Wei

1

1 reference

28 May 2018

Bing Han

2

1 reference

28 May 2018

Xiao-yun Mao

3

1 reference

28 May 2018

Min-jie Wei

4

1 reference

28 May 2018

Fan Yao

5

1 reference

28 May 2018

Feng Jin

6

1 reference

28 May 2018

publication date

16 September 2011

1 reference

28 May 2018

published in

Tumor Biology

1 reference

28 May 2018

volume

33

1 reference

28 May 2018

issue

2

1 reference

28 May 2018

page(s)

413-420

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-011-0234-x

exact match

0 references

cites work

Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Family history and the risk of breast cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Regulation of mammary epithelial architecture by PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue micro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTestTM in breast carcinoma by image analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Race and family history assessment for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Deconstructing the molecular portrait of basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Hypermethylation of estrogen receptor-alpha gene in atheromatosis patients and its correlation with homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Mutations in p53, p53 protein overexpression and breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

p53 nuclear accumulation and ERalpha expression in ductal hyperplasia of breast in a cohort of 215 Chinese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

TP53 mutations in familial breast cancer: functional aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

p53 Overexpression is a Predictor of Local Recurrence After Treatment for Both in situ and Invasive Ductal Carcinoma of the Breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0234-X

Immunohistochemical expression of BRCA1 protein in invasive ductal carcinoma of the breast

21 January 2018

1 reference

12 December 2020

HER2/neu amplification in breast cancer: stratification by tumor type and grade

1 reference

12 December 2020

Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer

1 reference

12 December 2020

Mapping of ER gene CpG island methylation-specific polymerase chain reaction.

1 reference

12 December 2020

A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients

1 reference

12 December 2020

Genes, the environment, and breast cancer

1 reference

12 December 2020

Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients

1 reference

12 December 2020

The fundamental role of epigenetic events in cancer

1 reference

12 December 2020

10.1007/S13277-011-0234-X

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018